In contrast, both the protein and mRNA expression levels of active caspase‐3 and Bax were significantly higher in the Alzheimer's disease than in the control group and sham groups, while Bcl‐2 expression levels were significantly lower (P < .01). The gene discussed is BCL2; the disease is early-onset autosomal dominant Alzheimer disease.